The American Lung Association reports more than 150,000 people are hospitalized with pneumonia each year, leading to roughly ...

Add Yahoo as a preferred source to see more of our stories on Google. Apr. 9—(StatePoint) Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up (StatePoint) Pneumococcal pneumonia is a potentially serious ...

Clinical trials and meta-analyses examining the efficacy of pneumococcal polysaccharide vaccine (Pneumovax 23®) in adults have produced conflicting data. This Viewpoint discusses a study designed to ...

U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause pneumonia and other dangerous illnesses. The recommendation was made by a scientific ...

The Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) is an industry-sponsored (Pfizer) trial with the primary objective of showing the efficacy of a polysaccharide conjugate vaccine ...

(BPT) – May is National Asthma and Allergy Awareness Month — aimed at raising awareness around asthma and helping improve the lives of those living with this condition. Did you know that if you are an ...

Merck’s investigational pneumococcal vaccine V116 matched Pfizer’s Prevnar 20 vaccine in efficacy and safety, according to data from a Phase 3 trial released Tuesday morning. The trial, STRIDE-3, ...

Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...

Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt a person’s life for weeks. When severe, it can result in hospitalization and even be life threatening. Each year ...